Report cover image

Global Orexin Receptor Type 2 Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 185 Pages
SKU # APRC20552384

Description

Summary

According to APO Research, The global Orexin Receptor Type 2 market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Orexin Receptor Type 2 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Orexin Receptor Type 2 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Orexin Receptor Type 2 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Orexin Receptor Type 2 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Orexin Receptor Type 2 include Yangtze River Pharmaceutical Group, Eisai Co Ltd, Johnson & Johnson, Merck & Co Inc, OptiNose US Inc, Idorsia Ltd, Heptares Therapeutics Ltd, Evotec AG and Actelion Pharmaceuticals Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Orexin Receptor Type 2, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Orexin Receptor Type 2, also provides the revenue of main regions and countries. Of the upcoming market potential for Orexin Receptor Type 2, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Orexin Receptor Type 2 revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Orexin Receptor Type 2 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Orexin Receptor Type 2 revenue, projected growth trends, production technology, application and end-user industry.

Orexin Receptor Type 2 Segment by Company

Yangtze River Pharmaceutical Group
Eisai Co Ltd
Johnson & Johnson
Merck & Co Inc
OptiNose US Inc
Idorsia Ltd
Heptares Therapeutics Ltd
Evotec AG
Actelion Pharmaceuticals Ltd
Orexin Receptor Type 2 Segment by Type

HTL-6641
MK-8133
OPN-021
YNT-185
Lemborexant
Others
Orexin Receptor Type 2 Segment by Application

Major Depressive Disorder
Sleep Disorders
Narcolepsy
Insomnia
Orexin Receptor Type 2 Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orexin Receptor Type 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Orexin Receptor Type 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orexin Receptor Type 2.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Orexin Receptor Type 2 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Orexin Receptor Type 2 industry.
Chapter 3: Detailed analysis of Orexin Receptor Type 2 companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Orexin Receptor Type 2revenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

185 Pages
1 Market Overview
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Orexin Receptor Type 2 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 HTL-6641
1.2.3 MK-8133
1.2.4 OPN-021
1.2.5 YNT-185
1.2.6 Lemborexant
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Global Orexin Receptor Type 2 Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
1.3.2 Major Depressive Disorder
1.3.3 Sleep Disorders
1.3.4 Narcolepsy
1.3.5 Insomnia
1.4 Global Market Growth Prospects
1.5 Global Orexin Receptor Type 2 Growth Trends by Region
1.5.1 Global Orexin Receptor Type 2 Market Size by Region: 2020 VS 2024 VS 2031
1.5.2 Orexin Receptor Type 2 Market Size by Region (2020-2025)
1.5.3 Orexin Receptor Type 2 Market Size by Region (2026-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 Global Orexin Receptor Type 2 Market Dynamics
2.1 Orexin Receptor Type 2 Industry Trends
2.2 Orexin Receptor Type 2 Industry Drivers
2.3 Orexin Receptor Type 2 Industry Opportunities and Challenges
2.4 Orexin Receptor Type 2 Industry Restraints
3 Competitive Landscape by Company
3.1 Global Orexin Receptor Type 2 Revenue by Company (2020-2025)
3.2 Global Orexin Receptor Type 2 Players Revenue Ranking, 2023 VS 2024 VS 2025
3.3 Global Orexin Receptor Type 2 Key Company Head office and Area Served
3.4 Global Orexin Receptor Type 2 Company, Product Type & Application
3.5 Global Orexin Receptor Type 2 Company Establishment Date
3.6 Market Competitive Analysis
3.6.1 Global Orexin Receptor Type 2 Market CR5 and HHI
3.6.2 Global Top 5 and 10 Orexin Receptor Type 2 Players Market Share by Revenue in 2024
3.6.3 2024 Orexin Receptor Type 2 Tier 1, Tier 2, and Tier 3
4 Orexin Receptor Type 2 Market by Type
4.1 Global Orexin Receptor Type 2 Market Size by Type (2020 VS 2024 VS 2031)
4.2 Global Orexin Receptor Type 2 Market Size by Type (2020-2031)
4.3 Global Orexin Receptor Type 2 Market Size Share by Type (2020-2031)
5 Orexin Receptor Type 2 Market by Application
5.1 Global Orexin Receptor Type 2 Market Size by Application (2020 VS 2024 VS 2031)
5.2 Global Orexin Receptor Type 2 Market Size by Application (2020-2031)
5.3 Global Orexin Receptor Type 2 Market Size Share by Application (2020-2031)
6 Company Profiles
6.1 Yangtze River Pharmaceutical Group
6.1.1 Yangtze River Pharmaceutical Group Comapny Information
6.1.2 Yangtze River Pharmaceutical Group Business Overview
6.1.3 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2020-2025)
6.1.4 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Product Portfolio
6.1.5 Yangtze River Pharmaceutical Group Recent Developments
6.2 Eisai Co Ltd
6.2.1 Eisai Co Ltd Comapny Information
6.2.2 Eisai Co Ltd Business Overview
6.2.3 Eisai Co Ltd Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2020-2025)
6.2.4 Eisai Co Ltd Orexin Receptor Type 2 Product Portfolio
6.2.5 Eisai Co Ltd Recent Developments
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Comapny Information
6.3.2 Johnson & Johnson Business Overview
6.3.3 Johnson & Johnson Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2020-2025)
6.3.4 Johnson & Johnson Orexin Receptor Type 2 Product Portfolio
6.3.5 Johnson & Johnson Recent Developments
6.4 Merck & Co Inc
6.4.1 Merck & Co Inc Comapny Information
6.4.2 Merck & Co Inc Business Overview
6.4.3 Merck & Co Inc Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2020-2025)
6.4.4 Merck & Co Inc Orexin Receptor Type 2 Product Portfolio
6.4.5 Merck & Co Inc Recent Developments
6.5 OptiNose US Inc
6.5.1 OptiNose US Inc Comapny Information
6.5.2 OptiNose US Inc Business Overview
6.5.3 OptiNose US Inc Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2020-2025)
6.5.4 OptiNose US Inc Orexin Receptor Type 2 Product Portfolio
6.5.5 OptiNose US Inc Recent Developments
6.6 Idorsia Ltd
6.6.1 Idorsia Ltd Comapny Information
6.6.2 Idorsia Ltd Business Overview
6.6.3 Idorsia Ltd Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2020-2025)
6.6.4 Idorsia Ltd Orexin Receptor Type 2 Product Portfolio
6.6.5 Idorsia Ltd Recent Developments
6.7 Heptares Therapeutics Ltd
6.7.1 Heptares Therapeutics Ltd Comapny Information
6.7.2 Heptares Therapeutics Ltd Business Overview
6.7.3 Heptares Therapeutics Ltd Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2020-2025)
6.7.4 Heptares Therapeutics Ltd Orexin Receptor Type 2 Product Portfolio
6.7.5 Heptares Therapeutics Ltd Recent Developments
6.8 Evotec AG
6.8.1 Evotec AG Comapny Information
6.8.2 Evotec AG Business Overview
6.8.3 Evotec AG Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2020-2025)
6.8.4 Evotec AG Orexin Receptor Type 2 Product Portfolio
6.8.5 Evotec AG Recent Developments
6.9 Actelion Pharmaceuticals Ltd
6.9.1 Actelion Pharmaceuticals Ltd Comapny Information
6.9.2 Actelion Pharmaceuticals Ltd Business Overview
6.9.3 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2020-2025)
6.9.4 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Product Portfolio
6.9.5 Actelion Pharmaceuticals Ltd Recent Developments
7 North America
7.1 North America Orexin Receptor Type 2 Market Size (2020-2031)
7.2 North America Orexin Receptor Type 2 Market Size by Type
7.2.1 North America Orexin Receptor Type 2 Market Size by Type (2020-2025)
7.2.2 North America Orexin Receptor Type 2 Market Size by Type (2026-2031)
7.2.3 North America Orexin Receptor Type 2 Market Share by Type (2020-2031)
7.3 North America Orexin Receptor Type 2 Market Size by Application
7.3.1 North America Orexin Receptor Type 2 Market Size by Application (2020-2025)
7.3.2 North America Orexin Receptor Type 2 Market Size by Application (2026-2031)
7.3.3 North America Orexin Receptor Type 2 Market Share by Application (2020-2031)
7.4 North America Orexin Receptor Type 2 Market Size by Country
7.4.1 North America Orexin Receptor Type 2 Market Size by Country (2020 VS 2024 VS 2031)
7.4.2 North America Orexin Receptor Type 2 Market Size by Country (2020-2025)
7.4.3 North America Orexin Receptor Type 2 Market Size by Country (2026-2031)
7.4.4 North America Orexin Receptor Type 2 Market Share by Country (2020-2031)
7.4.5 United States
7.4.6 Canada
7.4.7 Mexico
8 Europe
8.1 Europe Orexin Receptor Type 2 Market Size (2020-2031)
8.2 Europe Orexin Receptor Type 2 Market Size by Type
8.2.1 Europe Orexin Receptor Type 2 Market Size by Type (2020-2025)
8.2.2 Europe Orexin Receptor Type 2 Market Size by Type (2026-2031)
8.2.3 Europe Orexin Receptor Type 2 Market Share by Type (2020-2031)
8.3 Europe Orexin Receptor Type 2 Market Size by Application
8.3.1 Europe Orexin Receptor Type 2 Market Size by Application (2020-2025)
8.3.2 Europe Orexin Receptor Type 2 Market Size by Application (2026-2031)
8.3.3 Europe Orexin Receptor Type 2 Market Share by Application (2020-2031)
8.4 Europe Orexin Receptor Type 2 Market Size by Country
8.4.1 Europe Orexin Receptor Type 2 Market Size by Country (2020 VS 2024 VS 2031)
8.4.2 Europe Orexin Receptor Type 2 Market Size by Country (2020-2025)
8.4.3 Europe Orexin Receptor Type 2 Market Size by Country (2026-2031)
8.4.4 Europe Orexin Receptor Type 2 Market Share by Country (2020-2031)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 China
9.1 China Orexin Receptor Type 2 Market Size (2020-2031)
9.2 China Orexin Receptor Type 2 Market Size by Type
9.2.1 China Orexin Receptor Type 2 Market Size by Type (2020-2025)
9.2.2 China Orexin Receptor Type 2 Market Size by Type (2026-2031)
9.2.3 China Orexin Receptor Type 2 Market Share by Type (2020-2031)
9.3 China Orexin Receptor Type 2 Market Size by Application
9.3.1 China Orexin Receptor Type 2 Market Size by Application (2020-2025)
9.3.2 China Orexin Receptor Type 2 Market Size by Application (2026-2031)
9.3.3 China Orexin Receptor Type 2 Market Share by Application (2020-2031)
10 Asia (Excluding China)
10.1 Asia Orexin Receptor Type 2 Market Size (2020-2031)
10.2 Asia Orexin Receptor Type 2 Market Size by Type
10.2.1 Asia Orexin Receptor Type 2 Market Size by Type (2020-2025)
10.2.2 Asia Orexin Receptor Type 2 Market Size by Type (2026-2031)
10.2.3 Asia Orexin Receptor Type 2 Market Share by Type (2020-2031)
10.3 Asia Orexin Receptor Type 2 Market Size by Application
10.3.1 Asia Orexin Receptor Type 2 Market Size by Application (2020-2025)
10.3.2 Asia Orexin Receptor Type 2 Market Size by Application (2026-2031)
10.3.3 Asia Orexin Receptor Type 2 Market Share by Application (2020-2031)
10.4 Asia Orexin Receptor Type 2 Market Size by Country
10.4.1 Asia Orexin Receptor Type 2 Market Size by Country (2020 VS 2024 VS 2031)
10.4.2 Asia Orexin Receptor Type 2 Market Size by Country (2020-2025)
10.4.3 Asia Orexin Receptor Type 2 Market Size by Country (2026-2031)
10.4.4 Asia Orexin Receptor Type 2 Market Share by Country (2020-2031)
10.4.5 Japan
10.4.6 South Korea
10.4.7 Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 South America, Middle East & Africa
11.1 South America, Middle East & Africa Orexin Receptor Type 2 Market Size (2020-2031)
11.2 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Type
11.2.1 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Type (2020-2025)
11.2.2 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Type (2026-2031)
11.2.3 South America, Middle East & Africa Orexin Receptor Type 2 Market Share by Type (2020-2031)
11.3 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Application
11.3.1 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Application (2020-2025)
11.3.2 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Application (2026-2031)
11.3.3 South America, Middle East & Africa Orexin Receptor Type 2 Market Share by Application (2020-2031)
11.4 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Country
11.4.1 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Country (2020 VS 2024 VS 2031)
11.4.2 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Country (2020-2025)
11.4.3 South America, Middle East & Africa Orexin Receptor Type 2 Market Size by Country (2026-2031)
11.4.4 South America, Middle East & Africa Orexin Receptor Type 2 Market Share by Country (2020-2031)
11.4.5 Brazil
11.4.6 South Africa
11.4.7 Saudi Arabia
11.4.8 Turkey
11.4.9 Argentina
11.4.9 UAE
11.4.9 Egypt
11.4.9 Chile
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.